Mendoza-Sánchez F, Mendoza-Medina DF, Vilatoba-Chapa M, Contreras-Saldívar AG, Reynoso-Betancourt JA, Flores-Chávez LM, Dueńas-Pérez GM

Language: Spanish
References: 20
Page: 60-62
PDF size: 335.87 Kb.

ABSTRACT

Orthotopic liver transplantation is a highly effective procedure for several irreversible acute and chronic liver diseases for which there is no satisfactory therapy and represents the best treatment option for these diseases. Currently the results have been satisfactory, survival is usually in several transplant centers has been reported from 85% at one year and 75% at 5 years; in emerging and developing countries they have not achieved these results neither have been achieved or develop liver programs with efficiently, with few exceptions. Developed countries have used various models to assess liver transplantation programs: the efficiency index; designed to define the percentage of efficiency of each program compared their full potential activity; the methods suggested by the Consensus Conference sponsored by The Scientific Registry of Transplant Recipients (SRTR), The OPTN (Organ Procurement and Transplantation Network) and the Bayesian method among others (distribution method posterior probability) showing whether programs are better or worse in relation to the average of the results. In non-developed countries this methods are not applied and have not been published. We consider liver transplantation programs should be evaluated promptly and objectively, taking into account recommendations consensus scientific methods and evaluation. In developing countries, the full availability of resources is an important factor that should be considered in the evaluation of programs.

REFERENCES

1. Starzl TE, Iwatsuki S, Van Thiel DH, Gartner JC, Zitelli BJ, Malatack JJ et al. Evolution of liver transplantation. Hepatology. 1982; 2 (5): 614-636.

2. Moore FD, Wheele HB, Demissianos HV, Smith LL, Balankura O, Abel K et al. Experimental whole-organ transplantation of the liver and of the spleen. Ann Surg. 1960; 152: 374-387.

3. Starlz TE, Kaupp HA Jr, Brock DR, Lazarus RE, Johnson RV. Reconstructive problems in canine liver homotransplantation with special reference to the postoperative role of hepatic venous flow. Surg Gynecol Obstet. 1960; 111: 733-743.

4. Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet. 1963; 117: 659-676.

5. Starzl TE, Groth CG, Brettschneider L, Moon JB, Fulginiti VA, Cotton EK et al. Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery. 1968; 63 (4): 549-563.

6. UNOS (United Network for Organ Sharing) and OPTN (Organ Procurement & Transplantation Network), US Department of Health & Human Services, (www.unos.org). [Información obtenida el 18 de agosto, 2015.]

7. Jain A, Reyes J, Kashyap R, Dodson SF, Demetris AJ, Ruppert K et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg. 2000; 232 (4): 490-500.

8. Bulletin of the World Health Organization. Diciembre 2007, 85 (12).

9. World Health Organization, New world observatory launched with Spain, the second Global Consultation on Transplantation. Geneva; marzo 2007,

10. Ghirardini A, Nanni-Costa A, Venturi S, Ridolfi L, Petrini F, Taddei S et al. Efficiency of organ procurement and transplantation programs. Transpl Int. 2000; 13 Suppl 1: S267-S271.

11. Global Observatory on Donation & Transplantation, World Health Organization, Gobierno de Espańa Ministerio de Sanidad, Servicios Sociales e Igualdad, Organización Nacional de Trasplantes de Espańa. Organ Donation on Transplantation Activities 2013.

12. Salvalaggio PR, Caicedo JC, de Albuquerque LC, Contreras A, Garcia VD, Felga GE et al. Liver transplantation in Latin America: the state-of-the-art and future trends. Transplantation. 2014; 98 (3): 241-246.

13. Kasiske BL, McBride MA, Cornell DL, Gaston RS, Henry ML, Irwin FD et al. Report of a consensus conference on transplant program quality and surveillance. Am J Transplant. 2012; 12 (8): 1988-1996.

14. Poloniecki J, Sismanidis C, Bland M, Jones P. Retrospective cohort of false alarm rates associated with a series of heart operations: the case for hospital mortality monitoring groups. BMJ. 2004; 328: 375-379.

15. Cohen ME, Dimick JB, Bilimoria KY, Ko CY, Richards K, Hall BL. Risk adjustment in the American College of Surgeons National Surgical Quality Improvement Program: a comparison of logistic versus hierarchical modeling. J Am Coll Surg. 2009; 209: 687-693.

16. Cholongitas E, Marelli L, Kerry A, Senzolo M, Goodier DW, Nair D et al. Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl. 2007; 13: 523-529.

17. Biau DJ, Resche-Rigon M, Godiris-Petit G, Nizard RS, Porcher R. Quality control of surgical and interventional procedures: a review of the CUSUM. Qual Saf Health Care. 2007; 16: 203-207.

18. Neuberger J, Madden S, Collett D. Review of methods for measuring and comparing center performance after organ transplantation. Liver Transpl. 2010; 16 (10): 1119-1128.

19. Ohlssen DI, Sharples LD, Spiegelhalter DJ. A hierarchical modeling framework for identifying unusual performance in health care providers. J R Stat Soc A. 2007; 170: 865-890.

20. Salkowski N, Snyder JJ, Zaun DA, Leighton T, Israni AK, Kasiske BL. Bayesian methods for assessing transplant program performance. Am J Transplant. 2014; 14 (6): 1271-1276.